Depleted enzyme stores in kidney cancer may get a boost in treatment
Anew study from the Perelman School of Medicine determined that “clear cell” renal cell carcinoma tumors are found to repress enzyme activity. Treatments that restore the depleted enzymes may expand options for kidney cancer patients.
FULL STORY AT Penn Medicine News →